Email this page: News Release
Vertex Announces Update to U.S. Prescribing Information for INCIVEK® (telaprevir)
To (email address):
Separate multiple addresses with commas. Maximum 200 characters.
Your email address:
These email addresses will be used to email the page on your behalf and will not be used by Vertex Pharmaceuticals Incorporated for any marketing purposes.
Add a comment:
Link to page
Type in number:
This helps Vertex Pharmaceuticals Incorporated prevent automated submissions.